We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

TSSI:NASDAQTSS, Inc. Analysis

Data as of 2026-08-31 - not real-time

$7.90

Latest Price

9/10Risk

Risk Level: High

Executive Summary

The moving-average structure behind TSS, Inc. is bearish at $7.90, with short-term averages lagging the long-term ones. Over a rolling month the price has lost 12.9%. Relative strength is 31.6 — approaching oversold — and the MACD signal is bearish. Recent trading has carved out support near $7.89 and resistance around $12.84.
Multiples put this in undervalued territory: 15.2 times earnings against the sector's 35.7. Consensus targets land 108.7% above where the shares trade now. Revenue is contracting at 20.1% on a 7.4% profit margin.
On a 1-10 scale the risk profile lands at 9 — high. With 30-day volatility of 95.0%, a beta of 3.39 and a maximum drawdown of 66.1%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 94 on the fear-greed composite.
Short, medium and long-term reads agree on hold, with conviction of 2/10.

Top Market Events

Systems integration revenue surges 46% as TSS Inc TSSI pivots toward AI infrastructure, boosting gross margins by 640...TSS Inc. TSSI came out with quarterly earnings of $0.05 per share, missing the Zacks Consensus Estimate of $0.08 per...TSS TSSI delivered earnings and revenue surprises of -37.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 3/10

Key Factors

  • Short-term moving averages stacked below long-term ones
  • Trading below the 200-day average of 10.87
  • MACD momentum is negative

Medium Term

1–3 years
Neutral
Model confidence: 1/10

Key Factors

  • Short-term moving averages stacked below long-term ones
  • P/E of 15.2 versus sector average of 35.7
  • Trading below the 200-day average of 10.87

Long Term

> 3 years
Neutral
Model confidence: 2/10

Key Factors

  • P/E of 15.2 versus sector average of 35.7
  • Analyst targets imply +108.7% versus the current price
  • Revenue contracting at -20.1%

Key Metrics & Analysis

Financial Health

Revenue Growth-20.10%
Profit Margin7.43%
P/E Ratio15.2
ROE32.00%
ROA3.73%
Debt/Equity48.28
P/B Ratio2.8
Op. Cash Flow$-9405000
Free Cash Flow$-27642124
Industry P/E35.7

Technical Analysis

TrendBearish
RSI31.6
Support$7.89
Resistance$12.84
MA 20$9.83
MA 50$10.43
MA 200$10.87
MACDBearish
VolumeDecreasing
Fear & Greed Index94.3

Valuation

Target Price$16.50
Upside/Downside108.74%
GradeUndervalued
TypeBlend

Risk Assessment

Beta3.39
Volatility94.96%
Sector RiskHigh
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.